Clinical Trials Directory

Trials / Unknown

UnknownNCT04037384

Training of Eye Movements in Glaucoma

Alternative Home Training Possibilities for Glaucoma Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
University of Magdeburg · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The aim of the trial is to investigate the possibilities of improving visual impairments with eye training exercises (eye-yoga) in a total of 40 patients with glaucoma who have not previously been treated within a similar training program. 20 patients will be instructed how to do eye yoga to be performed dails for 4 weeks (max 30 min/day). As a control group of 20 patients will be instructed to read for 30 min/day for 4 weeks. The following outcome measures will be investigated: High Resolution Perimetry, Humphrey Perimetry, Visual Acuity Test, Contrast Sensitivity Test, Microsaccades measurements, Intraocular Pressure Measurement, Electroencephalogram (EEG), Blood Pressure and Pulse Measurement and Dynamic Vessel Analysis (DVA - the blood supply in the eye (especially vascular dysregulation) . Furthermore, factors that could influence response variability and the effectiveness of treatment will be analysed: (i) the role of mental stress (or stress resilience) and (ii) the influence of personality traits and quality of life. The study is intended to further validate this home training program (eye yoga) for the treatment of visual impairment in glaucoma.

Detailed description

The aim of eye yoga is to improve microsaccade impairments in patient with primary open angle glaucoma. We will study how this affects visual performance and the physiology of the eye and brain

Conditions

Interventions

TypeNameDescription
BEHAVIORALEye yogaEye yoga exercises at home given by a trained instructor
BEHAVIORALPassive ReadingPassive reading at home

Timeline

Start date
2019-08-01
Primary completion
2022-12-31
Completion
2023-08-01
First posted
2019-07-30
Last updated
2021-02-09

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT04037384. Inclusion in this directory is not an endorsement.